MyFinsight
Home
Blog
About
Contact
Back
Income Statement
Cadrenal Therapeutics, Inc. (CVKD)
Cadrenal Therapeutics, Inc. (CVKD)
source: myfinsight.com
Download
Download image
Interest and dividend
income
$17,838
Net loss and
comprehensive loss
-$2,496,540
Total other income
$17,838
Loss from operations
-$2,514,378
Total operating
expenses
$2,514,378
General and
administrative expenses
$1,742,315
Research and development
expenses
$771,508
Depreciation expense
$555
Back